Vaccine Considerations for Multiple Sclerosis in the COVID-19 Era.

ABSTRACT: People with multiple sclerosis (MS) are at risk for infections that can result in amplification of baseline symptoms and possibly trigger clinical relapses. Vaccination can prevent infection through the activation of humoral and cellular immune responses. This is particularly pertinent in the era of emerging novel vaccines against severe acute respiratory syndrome coronavirus 2, the virus that causes coronavirus disease 2019 (COVID-19). MS disease-modifying therapies (DMTs), which affect the immune system, may impact immune responses to COVID-19 vaccines in people with MS. The objective of this article is to provide information on immune system responses to vaccinations and review previous studies of vaccine responses in people with MS to support the safety and importance of receiving curr

SUBMITTER: Coyle PK 

PROVIDER: S-EPMC8169434 | biostudies-literature | 2021 Jul

REPOSITORIES: biostudies-literature